The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Genomind
Chalfont, United States
B
51-100 Employees
2009
Key takeaway
Genomind specializes in pharmacogenetic testing, offering actionable genetic insights that enhance personalized medicine and optimize treatment plans. Their platform integrates critical prescribing data, making it easier for healthcare providers to tailor medication strategies based on individual genetic profiles, thereby improving psychiatric care outcomes.
Reference
Product
Pharmacogenetic Testing - Genomind
Find out more about Genomind's flagship product: pharmacogenetic testing, or PGx testing (genetic testing for medicine).
RPRD Diagnostics
Milwaukee, United States
B
11-50 Employees
2016
Key takeaway
The company specializes in pharmacogenomics (PGx) solutions, offering a comprehensive testing platform that analyzes 4,627 markers within nearly 1,200 PGx genes, providing actionable insights to guide informed prescription decisions. Their innovative approaches and extensive genetic diagnostic testing aim to enhance personalized care and improve patient outcomes through precision medicine.
Reference
Core business
RPRDx - Science-Driven Innovations
RPRD Diagnostics offers high quality pharmacogenomics (PGx) solutions that is based on strong scientific evidence, and uses the latest innovations to enable precision medicine and improve patient care outcome.
Arpeggi Inc
Austin, United States
B
11-50 Employees
2012
Key takeaway
Gene By Gene specializes in pharmacogenomic testing, which studies how genetic variations affect individual responses to medications. Their expertise allows doctors to predict patients' reactions to drugs, helping to personalize treatment and enhance healthcare outcomes.
Reference
Service
Pharmacogenomic Testing | Gene by Gene – Laboratory Services
Pharmacogenomic Testing is enabling doctors to predict whether a patient may have a poor response or higher risk of side effects before prescribing medications. Gene by Gene is helping practitioners fast-track healthcare goals and enable personalization for every patient.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
PURE DIAGNOSTIC LLC
Chattanooga, United States
B
11-50 Employees
2016
Key takeaway
Pure Diagnostics Lab offers pharmacogenetic testing, which provides valuable insights into a patient's genetic predisposition to drug interactions and responses to certain medications. This service is essential for healthcare professionals in developing effective treatment plans.
Reference
Product
Pharmacogenomics - Pure Diagnostic
Read More
Fagron Genomics
Terrassa, Spain
A
11-50 Employees
2018
Key takeaway
Fagron Genomics specializes in developing medical genetic algorithms that enhance understanding of individual genetic variations, which can inform personalized treatment plans. Their approach includes innovative tools for optimizing diet, evaluating biological age, and tailoring acne treatments based on genetic insights.
Reference
Core business
Fagron Genomics
Home
Phamatech, Inc
San Diego, United States
B
101-250 Employees
1991
Key takeaway
Phamatech, Inc. specializes in pharmacogenetic testing, providing comprehensive and personalized assessments that help physicians identify how patients respond to medications. Their advanced testing detects genetic variations that influence drug metabolism, enhancing medication management and efficacy.
Reference
Service
Pharmacogenetics (PGx) - Phamatech Inc.
Pharmacogenetic Testing Phamatech, Inc. offers comprehensive, highly personalized, medication tailored pharmacogenetic testing that utilizes an FDA-cleared platform that assists physicians in identifying responders and non-responders to medications in their patients. Pharmacogenetic testing detects genetic variations (polymorphisms) that affect the function of key drug metabolizing enzymes, drug transporters, and targets. It predicts each person’s ability to
Phenomics Health
Ann Arbor, United States
B
- Employees
-
Key takeaway
Phenomics Health specializes in pharmacogenomic testing, providing a highly predictive profile of a patient's unique drug response. This focus on precision medicine spans various therapeutic areas, including chronic pain, mental illness, and cardiovascular disease.
Reference
Core business
Company - Phenomics Health
The only precision medicine company to offer both Pharmacogenomic and Pharmacometabolomic testing.
IMGM Laboratories GmbH
Planegg, Germany
A
11-50 Employees
2001
Key takeaway
IMGM is a specialized outsourcing partner focusing on pharmacogenetics, among other areas like metagenomics and biomarker discovery. They leverage advanced technologies and data analysis to support the needs of international life science partners, ensuring high-quality results that can aid in the development of innovative therapies and diagnostics.
Reference
Service
IMGM Laboratories GmbH - Pharmacogenetics
Pharma GenLabs
Youngstown, United States
B
11-50 Employees
-
Key takeaway
Pharma GenLabs offers Pharmacogenomic (PGx) testing, which helps identify how specific patients metabolize drugs and the potential for drug interactions based on their genetic makeup. This capability enhances patient care by guiding medical professionals in selecting the most effective treatments tailored to individual genetic profiles.
Reference
Core business
About Us | Pharma GenLabs
Pharma GenLabs is a Molecular Diagnostic Laboratory with the ability to determine various pathogens and the medications that are resistant to those pathogens to increase patient care and improve outcomes. We test pathogen and human genomes in order to determine the medication or medications that are most effective against the pathogen and align with the genetics of individuals.
INTLAB AG
Zurich, Switzerland
A
11-50 Employees
-
Key takeaway
INTLAB's SONOGEN system focuses on personalized therapy through pharmacogenetics, aiming to make tailored medication accessible for safe and effective treatment. Their commitment to integrating pharmacogenetics into clinical practice underscores their expertise in personalized precision medicine.
Reference
Core business
INTLAB AG - Pharmacogenetics expertise throughout Europe
Swiss company for personalized precision medicine. We bring pharmacogenetics into clinical practice.
Technologies which have been searched by others and may be interesting for you:
Pharmacogenomics is the study of how an individual's genetic makeup influences their response to medications. This field combines pharmacology, the science of drugs, and genomics, the study of genes and their functions. By analyzing genetic variations, pharmacogenomics aims to optimize drug therapy, improve efficacy, and minimize adverse effects. It allows healthcare providers to tailor medications to the patient's genetic profile, ensuring more personalized and effective treatment plans. As a result, pharmacogenomics holds significant potential in enhancing patient outcomes and advancing precision medicine.
Pharmacogenomics plays a critical role in optimizing medication effectiveness by analyzing how an individual's genetic makeup influences their response to drugs. By understanding genetic variations, healthcare providers can tailor drug selection and dosing to each patient, reducing the risk of adverse reactions and improving therapeutic outcomes. The integration of pharmacogenomic data into clinical practice allows for personalized medicine. This means that treatments can be customized based on genetic testing results, ensuring that patients receive the most suitable medications for their specific genetic profiles. As a result, pharmacogenomics enhances the precision of treatment, leading to more effective and safer healthcare interventions.
1. Personalized Treatment Plans
Pharmacogenomics allows healthcare providers to tailor medication choices based on a patient's genetic makeup. This leads to more effective treatment plans that can enhance therapeutic outcomes and minimize adverse drug reactions.
2. Improved Drug Efficacy
By understanding how a patient's genetic variations affect drug metabolism, pharmacogenomics helps in selecting medications that are more likely to work effectively for specific individuals. This targeted approach increases the likelihood of successful treatment and reduces the trial-and-error process often associated with prescribing medications.
Pharmacogenomic testing is typically performed through a simple process that involves collecting a sample from the patient, usually in the form of a blood draw or a cheek swab. This sample is then sent to a specialized laboratory where the DNA is extracted and analyzed for specific genetic variations that affect drug metabolism. Once the genetic analysis is complete, healthcare providers receive a report detailing the findings. This report helps clinicians understand how a patient might respond to certain medications, allowing for more personalized treatment plans. By considering these genetic factors, providers can optimize drug selection and dosages, improving therapeutic outcomes and minimizing adverse effects.
Implementing pharmacogenomics presents several challenges that can hinder its effective integration into healthcare systems. A significant hurdle is the complexity of genetic data interpretation. Healthcare providers often lack the necessary training to interpret pharmacogenomic information accurately, which can lead to misinformed prescribing decisions. Additionally, regulatory and reimbursement issues complicate the landscape. Many insurance companies are still hesitant to provide coverage for pharmacogenomic testing, limiting access for patients. There is also a need for robust clinical guidelines to ensure consistent application of pharmacogenomic findings across various healthcare settings, which is currently lacking. These challenges must be addressed to fully realize the potential of pharmacogenomics in personalized medicine.
Some interesting numbers and facts about your company results for Pharmacogenomic
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 6133 |
| Amount of suitable service providers | 5669 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1991 |
| Youngest suiting company | 2018 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Pharmacogenomic
What are related technologies to Pharmacogenomic?
Based on our calculations related technologies to Pharmacogenomic are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Pharmacogenomic?
The most represented industries which are working in Pharmacogenomic are Biotechnology, Pharmaceuticals, Other, Healthcare, IT, Software and Services
How does ensun find these Pharmacogenomic Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
